PURE Bioscience (OTCMKTS:PURE – Get Free Report)’s share price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.06 and traded as high as $0.07. PURE Bioscience shares last traded at $0.0627, with a volume of 49,975 shares.
PURE Bioscience Stock Performance
The company’s 50 day simple moving average is $0.07 and its 200-day simple moving average is $0.06. The firm has a market capitalization of $8.15 million, a PE ratio of -2.09 and a beta of 0.22.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last released its quarterly earnings results on Monday, June 15th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.51 million for the quarter.
About PURE Bioscience
PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.
PURE’s product suite includes concentrate formulations and ready-to-use solutions.
Read More
- Five stocks we like better than PURE Bioscience
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
- MarketBeat Week in Review – 07/06 – 07/10
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
